Ginkgo Bioworks Holdings Inc (DNA) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,89%	1 083,04	−9,76	−0,89%	—	1 092,80	1 093,68	1 094,85	1 081,97	—	—
SIXC Communications SIXC Communications	SIXC −0,39%	602,38	−2,36	−0,39%	—	604,74	604,74	605,10	601,34	—	—
SIXE Energy SIXE Energy	SIXE +2,31%	1 242,83	+28,03	+2,31%	—	1 214,80	1 220,81	1 243,82	1 220,81	—	—
SIXI Industrials SIXI Industrials	SIXI −0,62%	1 713,82	−10,75	−0,62%	—	1 724,57	1 727,02	1 732,30	1 707,43	—	—
SIXM Financials SIXM Financials	SIXM +0,09%	639,99	+0,56	+0,09%	—	639,43	641,58	644,53	637,50	—	—
SIXR Staples SIXR Staples	SIXR −0,20%	837,46	−1,69	−0,20%	—	839,15	836,90	840,48	832,89	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,65%	214,22	−1,40	−0,65%	—	215,62	215,62	216,21	213,48	—	—
SIXT Technology SIXT Technology	SIXT +0,78%	3 204,38	+24,86	+0,78%	—	3 179,52	3 191,50	3 205,09	3 177,75	—	—
SIXU Utilities SIXU Utilities	SIXU −1,23%	925,38	−11,53	−1,23%	—	936,91	935,42	937,17	923,20	—	—
SIXV Health care SIXV Health care	SIXV −0,69%	1 442,71	−10,06	−0,69%	—	1 452,77	1 445,93	1 447,43	1 434,91	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,16%	2 361,34	−3,84	−0,16%	—	2 365,18	2 353,64	2 368,10	2 347,80	—	—

DNA:NYSE

Ginkgo Bioworks Holdings Inc

7,50 USD

−4,28%

(−0,34) 1 D

7,50 USD

0,00% (0,00)

Før børsåpning

Stengt: 29. apr., 16:00:02 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for DNA …

Åpne

7,75 USD

Høy

7,77 USD

Lav

7,17 USD

Markedsverdi

441,93 mill.

Snittvolum

1,20 mill.

Volum

4,97k

52 u høy

17,58 USD

52 u lav

5,37 USD

EPS

−5,64 USD

Beta

1,56

Utestående aksjer

49,94 mill.

Antall ansatte

485

Relaterte aksjer

Recursion Pharmaceuticals Inc

3,30 USD

0,00%

Nyhetssaker

Fra kilder på nettet

Stock Titan

for 57 minutter siden

Ginkgo Bioworks will take investor questions after May 7 results

Profil

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia

Om Ginkgo Bioworks Holdings Inc

Administrerende direktørJason Kelly

Ansatte485

Grunnlagt2008

HovedkontorBoston, Massachusetts, USA

Sektor-

Nettstedginkgo.bio

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	48,32 mill.	49,60 mill.	38,84 mill.	33,40 mill.
Varekostnad	12,05 mill.	14,82 mill.	12,80 mill.	7,30 mill.
Direkte driftskostnader	12,05 mill.	14,82 mill.	12,80 mill.	7,30 mill.
Utgifter til forskning og utvikling	70,92 mill.	53,37 mill.	69,35 mill.	50,13 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	49,04 mill.	43,28 mill.	44,95 mill.	46,01 mill.
Driftskostnader	119,97 mill.	96,65 mill.	114,31 mill.	96,14 mill.
Totale driftskostnader	132,01 mill.	111,47 mill.	127,11 mill.	103,44 mill.
Driftsinntekter	−83,70 mill.	−61,87 mill.	−88,27 mill.	−70,05 mill.
Andre ikke-operasjonelle inntekter	−4,29 mill.	−896,00k	−163,00k	821,00k
EBT inkludert uvanlige elementer	−90,87 mill.	−60,58 mill.	−80,75 mill.	−81,39 mill.
EBT uten uvanlige elementer	−81,90 mill.	−56,68 mill.	−82,69 mill.	−62,01 mill.
Kostnad for inntektsskatt	88,00k	−283,00k	1,00k	−643,00k
Faktisk avgiftssats	−0,10 %	0,47 %	-	0,79 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	−90,96 mill.	−60,30 mill.	−80,76 mill.	−80,75 mill.
Netto fortjenestemargin	−188,25 %	−121,56 %	−207,93 %	−241,80 %
Resultat per aksje	-	-	-	−0,77
Rente- og investeringsinntekter	6,08 mill.	6,08 mill.	5,74 mill.	7,21 mill.
Rentekostnader	-	-	-	-
Netto rentekostnader	6,08 mill.	6,08 mill.	5,74 mill.	7,21 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−68,33 mill.	−46,07 mill.	−88,10 mill.	−61,08 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning